Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Holding a Web-Meeting
Articles
India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018
India Globalization Capital, Inc. (NYSE American: IGC) this morning provided compelling in vitro data
As Recreational Cannabis Legalization Looms, the Field of Opportunity is Green for Canada’s Leading Growers
Sweeping legislation has been introduced by the Canadian government that takes aim at permitting nationwide recreational cannabis use by July 2018—a move applauded by companies that are currently licensed to produce medical marijuana in Canada or are engaged in providing services to growers.
Cannabis Wheaton Announces Appointment of New Advisory Board Member
Cannabis Wheaton Income Corp. (TSX VENTURE:CBW) is pleased to announce the appointment of Manon Grand-Maitre to the Advisory Board of Cannabis Wheaton.
Senator Cory Booker Tries to Legalize Marijuana Nationally
Earlier this week, Sen. Cory Booker (D-NJ) introduced legislation that would begin to end the unfair prohibition of marijuana throughout the federal government. The bill would also serve to repair the damage done to the country via prohibition.
Booker was quoted stating that “I believe the federal government should get out of the illegal marijuana business. You see what’s happening around this country right now. Eight states and the District of Columbia have moved to legalize marijuana.
Canopy Growth Corporation : Reiterates Stance on International Markets
In response to multiple media reports regarding US market participation and security regulations, and as stated in a press release dated June 19th, 2017 , Canopy Growth Corporation (TSX: WEED) wishes to reiterate its commitment to only conducting its business in jurisdictions where it is federally legal to do so.
Cannabis Financial Issues Topic of Symposium For CPAs, Lawyers, Bankers Advising Sellers
What are the risks and opportunities for financial professionals serving cannabis industry clients? The California Cannabis Industry Symposium will explore that question August 11 at the Radisson Oakland Airport.
India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease.
ChineseInvestors.com, Inc. (CIIX) Seen Benefitting from Senate Committee Vote for Amendment Protecting Legal Cannabis
ChineseInvestors.com, Inc. (OTCQB: CIIX) and other cannabis companies were overjoyed by the July 27 affirmative voice vote by the Senate Appropriations Committee to approve an amendment to a “2018 Commerce, Justice and Science Bill” that bars the federal government from using federal funds to investigate medical marijuana cases within states that have legalized medical marijuana.
ABcann Global Corporation (ABCN:CA) Appoints W. Brett Wilson to Advisory Board
In a news release issued earlier this week, ABcann Global Corporation (ABCN:CA) announced the appointment of W. Brett Wilson to its advisory board in connection with the company’s acquisition of ABcann Medicinals Inc.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on INM-405 Development
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment of pain.
ABcann Medicinals (TSXV: ABCN) Has Strong Start with Canadian TSX Venture Exchange Listing
Going public appears to be paying off for ABcann Medicals (TSXV: ABCN), since the medical cannabis grower launched its initial public offering (IPO) on the TSX Venture Exchange.
Isodiol International Inc. Releases Corporate Update
Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (Frankfurt:LB6A.F) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces unaudited July 2017 revenue numbers of its wholly owned subsidiary ISO International LLC of $1,358,787 USD .
ABcann Medicinals (TSXV: ABCN) Eyes Growing Role on Canadian Marijuana Market, Extends Agreement with MMJ Pioneer
Recently acquired by ABcann Global Corporation, an acquisition that came with a $26.8 million capital raise to help expand production, the company is already licensed to sell to the entire Canadian market and plans to significantly expand production to reach this goal.
Epilepsy Patients are the New Focus of ChineseInvestors.com, Inc.’s (CIIX) CBD Health Products
Many patients rely on Chinese herbs for temporary control. However, ChineseInvestors.com’s (OTCQB: CIIX) current development plan includes making cannabidiol (CBD) products available online for people with epilepsy and Alzheimer’s disease.